Liron Yoffe

12PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 05, 2026
Lipogenesis-driven EGFR palmitoylation enables metastatic immune evasion in triple-negative breast cancer.

|Nov 24, 2025
Propionate metabolism dysregulation promotes drug-tolerant persister cell survival in non-small cell lung cancer.

Bobak Parang, Liron Yoffe, Rabia Khan

|Oct 02, 2025
Epigenetic Regulation of Chromosomal Instability by EZH2 Methyltransferase.

Yang Bai, Albert S Agustinus, Shira Yomtoubian

|Jul 02, 2025
BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphoma.

Claudia Pignataro, Pietro Zoppoli, Luca Vincenzo Cappelli

|Jun 12, 2025
Tumor-specific draining lymph node CD8 T cells orchestrate an anti-tumor response to neoadjuvant PD-1 immune checkpoint blockade.

Rachel Honigsberg, Tatiana Cruz, Liron Yoffe

|Mar 03, 2025
Simultaneous immunomodulation and epithelial-to-mesenchymal transition drives lung adenocarcinoma progression.

Junbum Kim, Hiranmayi Ravichandran, Liron Yoffe

Pageof 2

Frequent Collaborators

3 joint publications

Danilo Fiore

3 joint publications

Luca Vincenzo Cappelli

3 joint publications

Vivek Mittal

3 joint publications

Olivier Elemento